SCHEMBL25329428

SCHEMBL25329428

CSCc1cncc(NC(=O)O)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 4/20 0.42
▸ RAB9A P51151 4/20 0.42
▸ SMN1; SMN2 Q16637 3/20 0.42
▸ LMNA P02545 1/20 0.42
▸ KDM4E B2RXH2 2/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ HCAR2 Q8TDS4 2/20 0.34
▸ MAPT P10636 3/20 0.34
▸ FDPS P14324 1/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ NAMPT P43490 1/20 0.34
▸ KDM1A O60341 1/20 0.33
▸ RCOR1 Q9UKL0 1/20 0.33
▸ TRPV1 Q8NER1 1/20 0.33
▸ XDH P47989 1/20 0.32
▸ SLC22A12 Q96S37 1/20 0.32
▸ CNR1 P21554 1/20 0.32
▸ POLB P06746 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30530861 0.80 CYP17A1 (0.45) NAMPT
SCHEMBL17161607 0.80 SCN10A (0.43) NPC1RAB9ASMN1; SMN2KDM4EALDH1A1
SCHEMBL25328772 0.78 CNR1 (0.37) NPC1RAB9ASMN1; SMN2LMNAKDM4E
SCHEMBL17912340 0.77 RAB9A (0.43) RAB9ASMN1; SMN2LMNAKDM4EALDH1A1
Hydrochloric Acid SCHEMBL17161625 0.77 CNR1 (0.36) NPC1RAB9ASMN1; SMN2LMNAKDM4E
SCHEMBL27961469 0.74 CYP11B2 (0.40) NPC1RAB9ASMN1; SMN2KDM4EALDH1A1
SCHEMBL1531663 0.73 HCAR2 (0.53) KDM4EALDH1A1HCAR2MAPT
SCHEMBL6035253 0.73 NOS3 (0.46) NPC1RAB9ALMNAALDH1A1MEN1
SCHEMBL17161617 0.72 BACE1 (0.33) NPC1RAB9AKDM4EALDH1A1FDPS
SCHEMBL12314762 0.71 TSHR (0.44) NPC1RAB9ALMNAKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023143135-A1 QUINAZOLINE DERIVATIVE AND USE THEREOF 赛诺哈勃药业(成都)有限公司 2023-08-03 — — WO disclosed
Send feedback